Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
In vascular disease states such as atherosclerosis and diabetes, endothelial nitric oxide (NO) bioactivity is reduced and oxidative stress is increased, resulting in endothelial dysfunction. Recent studies suggest that changes in the activity and regulation of endothelial NO synthase by its cofactor...
Autor principal: | Channon, K |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2004
|
Registos relacionados
-
Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.
Por: Alp, N, et al.
Publicado em: (2004) -
Regulation of endothelial nitric oxide synthase (eNOS) by tetrahydrobiopterin in vascular disease
Por: Alp, N, et al.
Publicado em: (2004) -
Tetrahydrobiopterin and nitric oxide synthase recouplers
Por: Channon, KM
Publicado em: (2020) -
Prevention of hypoxia-induced pulmonary hypertension and vascular remodelling by targeting endothelial tetrahydrobiopterin-dependent nitric oxide synthase regulation
Por: Khoo, J, et al.
Publicado em: (2005) -
Endothelial tetrahydrobiopterin deficiency accelerates atherosclerotic progression by nitric oxide synthase uncoupling
Por: Khoo, J, et al.
Publicado em: (2005)